363 related articles for article (PubMed ID: 25047726)
41. Broad-spectrum coronavirus antiviral drug discovery.
Totura AL; Bavari S
Expert Opin Drug Discov; 2019 Apr; 14(4):397-412. PubMed ID: 30849247
[TBL] [Abstract][Full Text] [Related]
42. Middle East Respiratory Syndrome (MERS).
Rasmussen SA; Watson AK; Swerdlow DL
Microbiol Spectr; 2016 Jun; 4(3):. PubMed ID: 27337460
[TBL] [Abstract][Full Text] [Related]
43. COVID-19 in the Shadows of MERS-CoV in the Kingdom of Saudi Arabia.
Barry M; Al Amri M; Memish ZA
J Epidemiol Glob Health; 2020 Mar; 10(1):1-3. PubMed ID: 32175703
[TBL] [Abstract][Full Text] [Related]
44. Comparative Epidemiology of Human Infections with Middle East Respiratory Syndrome and Severe Acute Respiratory Syndrome Coronaviruses among Healthcare Personnel.
Liu S; Chan TC; Chu YT; Wu JT; Geng X; Zhao N; Cheng W; Chen E; King CC
PLoS One; 2016; 11(3):e0149988. PubMed ID: 26930074
[TBL] [Abstract][Full Text] [Related]
45. Multiyear prospective cohort study to evaluate the risk potential of MERS-CoV infection among Malaysian Hajj pilgrims (MERCURIAL): a study protocol.
Johari J; Hontz RD; Pike BL; Husain T; Chong CK; Rusli N; Sulaiman LH; Verasahib K; Mohd Zain R; Azman AS; Khor CS; Nor'e SS; Tiong V; Lee HY; Teoh BT; Sam SS; Khoo JJ; Abd Jamil J; Loong SK; Yaacob CN; Mahfodz NH; Azizan NS; Che Mat Seri NAA; Mohd-Rahim NF; Hassan H; Yahaya H; Garcia-Rivera JA; AbuBakar S
BMJ Open; 2021 Aug; 11(8):e050901. PubMed ID: 34446498
[TBL] [Abstract][Full Text] [Related]
46. Middle East Respiratory Syndrome (MERS) coronavirus. What travel health advice should be given to Hajj pilgrims?
Gautret P
Travel Med Infect Dis; 2013; 11(5):263-5. PubMed ID: 24055442
[No Abstract] [Full Text] [Related]
47. Outbreak of Middle East respiratory syndrome coronavirus in Saudi Arabia: a retrospective study.
Aleanizy FS; Mohmed N; Alqahtani FY; El Hadi Mohamed RA
BMC Infect Dis; 2017 Jan; 17(1):23. PubMed ID: 28056850
[TBL] [Abstract][Full Text] [Related]
48. Middle East respiratory syndrome coronavirus: current situation and travel-associated concerns.
Al-Tawfiq JA; Omrani AS; Memish ZA
Front Med; 2016 Jun; 10(2):111-9. PubMed ID: 27146399
[TBL] [Abstract][Full Text] [Related]
49. From SARS and MERS to COVID-19: a brief summary and comparison of severe acute respiratory infections caused by three highly pathogenic human coronaviruses.
Zhu Z; Lian X; Su X; Wu W; Marraro GA; Zeng Y
Respir Res; 2020 Aug; 21(1):224. PubMed ID: 32854739
[TBL] [Abstract][Full Text] [Related]
50. Emerging Human Coronavirus Infections (SARS, MERS, and COVID-19): Where They Are Leading Us.
Kumar V
Int Rev Immunol; 2021; 40(1-2):5-53. PubMed ID: 32744465
[TBL] [Abstract][Full Text] [Related]
51. The unique features of SARS-CoV-2 transmission: Comparison with SARS-CoV, MERS-CoV and 2009 H1N1 pandemic influenza virus.
Wu Z; Harrich D; Li Z; Hu D; Li D
Rev Med Virol; 2021 Mar; 31(2):e2171. PubMed ID: 33350025
[TBL] [Abstract][Full Text] [Related]
52. A Comprehensive Review of Animal Models for Coronaviruses: SARS-CoV-2, SARS-CoV, and MERS-CoV.
Singh A; Singh RS; Sarma P; Batra G; Joshi R; Kaur H; Sharma AR; Prakash A; Medhi B
Virol Sin; 2020 Jun; 35(3):290-304. PubMed ID: 32607866
[TBL] [Abstract][Full Text] [Related]
53. Overview: The history and pediatric perspectives of severe acute respiratory syndromes: Novel or just like SARS.
Hon KL; Leung KKY; Leung AKC; Sridhar S; Qian S; Lee SL; Colin AA
Pediatr Pulmonol; 2020 Jul; 55(7):1584-1591. PubMed ID: 32483934
[TBL] [Abstract][Full Text] [Related]
54. Amplicon and Metagenomic Analysis of Middle East Respiratory Syndrome (MERS) Coronavirus and the Microbiome in Patients with Severe MERS.
Aljabr W; Alruwaili M; Penrice-Randal R; Alrezaihi A; Harrison AJ; Ryan Y; Bentley E; Jones B; Alhatlani BY; AlShahrani D; Mahmood Z; Rickett NY; Alosaimi B; Naeem A; Alamri S; Alsran H; Hamed ME; Dong X; Assiri AM; Alrasheed AR; Hamza M; Carroll MW; Gemmell M; Darby A; Donovan-Banfield I; Stewart JP; Matthews DA; Davidson AD; Hiscox JA
mSphere; 2021 Aug; 6(4):e0021921. PubMed ID: 34287009
[TBL] [Abstract][Full Text] [Related]
55. Lethal zoonotic coronavirus infections of humans - comparative phylogenetics, epidemiology, transmission, and clinical features of coronavirus disease 2019, The Middle East respiratory syndrome and severe acute respiratory syndrome.
Hui DS; Zumla A; Tang JW
Curr Opin Pulm Med; 2021 May; 27(3):146-154. PubMed ID: 33660619
[TBL] [Abstract][Full Text] [Related]
56. T-cell immunity of SARS-CoV: Implications for vaccine development against MERS-CoV.
Liu WJ; Zhao M; Liu K; Xu K; Wong G; Tan W; Gao GF
Antiviral Res; 2017 Jan; 137():82-92. PubMed ID: 27840203
[TBL] [Abstract][Full Text] [Related]
57. Animal models for SARS and MERS coronaviruses.
Gretebeck LM; Subbarao K
Curr Opin Virol; 2015 Aug; 13():123-9. PubMed ID: 26184451
[TBL] [Abstract][Full Text] [Related]
58. Human and novel coronavirus infections in children: a review.
Rajapakse N; Dixit D
Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199
[TBL] [Abstract][Full Text] [Related]
59. Severe acute respiratory syndrome vs. the Middle East respiratory syndrome.
Hui DS; Memish ZA; Zumla A
Curr Opin Pulm Med; 2014 May; 20(3):233-41. PubMed ID: 24626235
[TBL] [Abstract][Full Text] [Related]
60. Epidemic and Emerging Coronaviruses (Severe Acute Respiratory Syndrome and Middle East Respiratory Syndrome).
Hui DS
Clin Chest Med; 2017 Mar; 38(1):71-86. PubMed ID: 28159163
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
